GKB Ophthalmics Limited Stock Price Today (NSE: GKB)
Fundamental Score
GKB Ophthalmics Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
GKB Ophthalmics Limited share price today is ₹62.37, down 7.49% on NSE/BSE as of 16 September 2026. GKB Ophthalmics Limited (GKB) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹29.49 (Cr). The 52-week high for GKB share price is ₹74.00 and the 52-week low is ₹60.30. At a P/E ratio of 15.48x, GKB is currently trading below its industry average P/E of 36.70x. The company has a Return on Equity (ROE) of 3.63% and a debt-to-equity ratio of 0.22.
GKB Ophthalmics Limited Share Price Chart — NSE/BSE Historical Performance
GKB Ophthalmics Limited share price chart: 19.34% return over the past month. 52-week high ₹74.00, 52-week low ₹60.30.
GKB Ophthalmics Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹65.80 | ₹66.12 | ₹62.20 | ₹62.37 | 916.00 (Cr) | |
| ₹64.79 | ₹67.44 | ₹64.79 | ₹67.42 | 340.00 (Cr) | |
| ₹65.00 | ₹67.00 | ₹63.51 | ₹64.79 | 2.67K (Cr) | |
| ₹68.00 | ₹68.00 | ₹64.00 | ₹65.09 | 5.47K (Cr) | |
| ₹72.00 | ₹74.00 | ₹65.00 | ₹66.43 | 17.48K (Cr) | |
| ₹68.95 | ₹71.77 | ₹65.00 | ₹71.52 | 7.20K (Cr) | |
| ₹64.00 | ₹68.00 | ₹62.25 | ₹65.25 | 1.46K (Cr) | |
| ₹65.00 | ₹66.00 | ₹63.01 | ₹63.97 | 13.01K (Cr) | |
| ₹66.33 | ₹66.99 | ₹65.80 | ₹65.80 | 68.00 (Cr) | |
| ₹67.44 | ₹67.44 | ₹67.00 | ₹67.00 | 37.00 (Cr) |
GKB Ophthalmics Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹67.44 | ₹74.00 | ₹62.20 | ₹62.37 | -7.52% | |
| ₹59.45 | ₹70.00 | ₹55.00 | ₹66.09 | +11.17% | |
| ₹62.14 | ₹64.29 | ₹55.00 | ₹58.00 | -6.66% | |
| ₹63.73 | ₹65.94 | ₹60.00 | ₹64.29 | +0.88% | |
| ₹69.00 | ₹70.74 | ₹60.61 | ₹63.73 | -7.64% | |
| ₹51.51 | ₹76.90 | ₹51.51 | ₹68.49 | +32.96% | |
| ₹55.50 | ₹64.99 | ₹51.05 | ₹52.50 | -5.41% | |
| ₹58.00 | ₹74.50 | ₹51.45 | ₹58.86 | +1.48% | |
| ₹50.99 | ₹60.00 | ₹48.15 | ₹57.11 | +12.00% | |
| ₹59.80 | ₹61.35 | ₹45.25 | ₹51.24 | -14.31% | |
| ₹69.36 | ₹69.36 | ₹54.35 | ₹59.62 | -14.04% | |
| ₹67.30 | ₹73.60 | ₹62.35 | ₹67.67 | +0.55% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
GKB Ophthalmics Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
GKB Ophthalmics Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GKB across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Attractive Valuation (P/E: 15.48 vs Industry: 36.70)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (112.47%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (21.25% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (80.28% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (80.28% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.22)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Healthy Liquidity Position (Current Ratio: 1.59)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (51.13%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (3.63%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Margin Pressure Concerns (3.02%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Negative Free Cash Flow (₹-9.40 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 1.79%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
GKB Ophthalmics Limited vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare GKB Ophthalmics Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
56.6/100 | ₹62.37₹62 | ₹29.49₹29.49 | 15.48Average 15.5 Average | 3.63%Poor 3.63% Poor | 11.00%Average 11.00% Average | 0.22Excellent 0.2 Excellent | 80.28%Excellent 80.28% Excellent | 21.25%Excellent 21.25% Excellent | 0.00% | |
Poly Medicure LimitedPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1724.00₹1724 | ₹17474.36₹17474.36 | 55.45Average 55.5 Average | 10.97%Average 10.97% Average | 14.28%Average 14.28% Average | 0.11Excellent 0.1 Excellent | 18.85%Excellent 18.85% Excellent | 18.98%Excellent 18.98% Excellent | 0.20% |
Fischer Medical Ventures LimitedFischer Medical... FISCHER • 524743 | 21.9/100 | ₹34.60₹35 | ₹2264.62₹2264.62 | 14.42Average 14.4 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.19Excellent 0.2 Excellent | — — | — — | 0.01% |
Tarsons Products LimitedTarsons Product... TARSONS • 543399 | 17.1/100 | ₹321.35₹321 | ₹1709.74₹1709.74 | 153.76Average 153.8 Average | 0.00%Poor 0.00% Poor | 4.87%Poor 4.87% Poor | 0.60Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Laxmi Dental LimitedLaxmi Dental Li... LAXMIDENTL • 544339 | 69.6/100 | ₹201.14₹201 | ₹1105.47₹1105.47 | 35.54Average 35.5 Average | 12.83%Average 12.83% Average | 12.34%Average 12.34% Average | 0.00Excellent 0.0 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹369.90₹370 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹468.00₹468 | ₹610.20₹610.20 | 30.06Average 30.1 Average | 18.16%Good 18.16% Good | 24.15%Excellent 24.15% Excellent | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹387.00₹387 | ₹464.52₹464.52 | 20.38Average 20.4 Average | 18.60%Good 18.60% Good | 23.74%Excellent 23.74% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
Nureca LimitedNureca Limited... NURECA • 543264 | 16.5/100 | ₹334.00₹334 | ₹318.70₹318.70 | 77.67Average 77.7 Average | 0.00%Poor 0.00% Poor | 3.30%Poor 3.30% Poor | 0.00Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹151.80₹152 | ₹293.54₹293.54 | 30.79Average 30.8 Average | 10.45%Average 10.45% Average | 19.30%Good 19.30% Good | 0.65Good 0.7 Good | — — | — — | 0.45% | |
38.2/100 | ₹103.25₹103 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Limited share price17474.36 Cr
- Fischer Medical Ventures Limited share price2264.62 Cr
- Tarsons Products Limited share price1709.74 Cr
- Laxmi Dental Limited share price1105.47 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
GKB Ophthalmics Limited Dividend History
Annual cash dividends paid by GKB — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2023 | ₹0.00 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
GKB Ophthalmics Limited Quarterly Performance
Latest quarterly metrics for GKB — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-3.97%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
112.47%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
21.25%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
80.28%
Compounded annual net profit growth over 5 years
GKB Ophthalmics Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for GKB — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
GKB Ophthalmics Limited Financial Statements
Annual income statement, balance sheet and cash flow for GKB Ophthalmics Limited (GKB) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for GKB Ophthalmics Limited
About GKB (GKB Ophthalmics Limited)
GKB Ophthalmics Ltd is a pioneering force in the global landscape of ophthalmic lens manufacturing, dedicated to enhancing vision and transforming lives through precision optics. W...ith a legacy spanning decades, GKB has established itself as a trusted provider of high-quality lens solutions, catering to the diverse needs of eye care professionals and patients worldwide. At the heart of GKB's success lies an unwavering commitment to innovation, leveraging cutting-edge technology and advanced materials to develop lenses that deliver superior clarity, comfort, and visual performance. From meticulously crafted single vision lenses to sophisticated progressive designs, GKB's comprehensive portfolio embodies excellence in optical engineering. Driven by a passion for precision and patient satisfaction, GKB Ophthalmics Ltd adheres to rigorous quality control standards throughout its manufacturing processes. Every lens undergoes meticulous inspection and testing to ensure optimal performance and compliance with international regulatory requirements. GKB understands that vision is precious and they strive to deliver products that meet the highest standards of quality and accuracy. The company's state-of-the-art facilities are equipped with advanced machinery and staffed by a team of highly skilled technicians and engineers, ensuring seamless production and consistent product quality. GKB is also committed to sustainable practices, minimizing environmental impact and promoting responsible manufacturing. Beyond manufacturing, GKB Ophthalmics Ltd fosters strong partnerships with eye care professionals, providing comprehensive support and educational resources to empower them in delivering exceptional patient care. The company believes in building lasting relationships based on trust, collaboration, and mutual success. GKB's global presence extends to numerous countries, enabling it to serve a diverse customer base and contribute to the advancement of eye care globally. With a vision to shape the future of optics, GKB Ophthalmics Ltd remains dedicated to innovation, quality, and customer satisfaction, continually striving to enhance vision and improve the lives of people around the world.
Company Details
Key Leadership
GKB Share Price: Frequently Asked Questions
What is the current share price of GKB Ophthalmics Limited?
GKB Ophthalmics Limited (GKB) trades at ₹62.37 on NSE and BSE. Market cap ₹29.49 (Cr). Educational data only.
What is the P/E ratio of GKB Ophthalmics Limited?
GKB Ophthalmics Limited has a P/E of 15.48x vs industry average 36.70x.
What is the Bull Run score for GKB Ophthalmics Limited?
GKB Ophthalmics Limited has a Bull Run score of 56.6/100 based on 25+ financial parameters.
Does GKB Ophthalmics Limited pay dividends?
GKB Ophthalmics Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of GKB Ophthalmics Limited?
GKB Ophthalmics Limited has ROE of 3.63%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of GKB Ophthalmics Limited?
GKB Ophthalmics Limited has debt-to-equity of 0.22.
Is GKB Ophthalmics Limited a good investment?
Bull Run gives GKB Ophthalmics Limited a score of 56.6/100. This is not investment advice — consult a SEBI-registered advisor.